DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Stock Fundamental Analysis
FRA:DBAN - Deutsche Boerse Ag - DE000A1TNUT7 - Common Stock - Currency: EUR
DBAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 106 industry peers in the Capital Markets industry. DBAN has an average financial health and profitability rating. DBAN is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year DBAN was profitable.
In the past year DBAN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DBAN reported negative net income in multiple years.
In multiple years DBAN reported negative operating cash flow during the last 5 years.
1.2 Ratios
DBAN's Return On Assets of 5.20% is fine compared to the rest of the industry. DBAN outperforms 75.47% of its industry peers.
DBAN has a Return On Equity (6.90%) which is in line with its industry peers.
With a decent Return On Invested Capital value of 4.00%, DBAN is doing good in the industry, outperforming 64.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.2% | ||
| ROE | 6.9% | ||
| ROIC | 4% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DBAN's Profit Margin of 43.72% is amongst the best of the industry. DBAN outperforms 86.79% of its industry peers.
DBAN's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 45.84%, DBAN belongs to the top of the industry, outperforming 84.91% of the companies in the same industry.
DBAN's Operating Margin has declined in the last couple of years.
DBAN has a Gross Margin of 95.08%. This is amongst the best in the industry. DBAN outperforms 93.40% of its industry peers.
DBAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 45.84% | ||
| PM (TTM) | 43.72% | ||
| GM | 95.08% |
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
2. Health
2.1 Basic Checks
Compared to 1 year ago, DBAN has less shares outstanding
The number of shares outstanding for DBAN has been increased compared to 5 years ago.
Compared to 1 year ago, DBAN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.78 indicates that DBAN is not a great score, but indicates only limited risk for bankruptcy at the moment.
DBAN has a better Altman-Z score (2.78) than 75.47% of its industry peers.
DBAN has a debt to FCF ratio of 11.27. This is a negative value and a sign of low solvency as DBAN would need 11.27 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 11.27, DBAN is doing good in the industry, outperforming 72.64% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that DBAN is not too dependend on debt financing.
DBAN's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. DBAN outperforms 72.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 11.27 | ||
| Altman-Z | 2.78 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
DBAN has a Current Ratio of 4.62. This indicates that DBAN is financially healthy and has no problem in meeting its short term obligations.
DBAN's Current ratio of 4.62 is amongst the best of the industry. DBAN outperforms 87.74% of its industry peers.
DBAN has a Quick Ratio of 4.62. This indicates that DBAN is financially healthy and has no problem in meeting its short term obligations.
DBAN's Quick ratio of 4.62 is amongst the best of the industry. DBAN outperforms 87.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.62 | ||
| Quick Ratio | 4.62 |
3. Growth
3.1 Past
DBAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.94%.
DBAN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.13% yearly.
DBAN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.08%.
Measured over the past years, DBAN shows a small growth in Revenue. The Revenue has been growing by 7.25% on average per year.
EPS 1Y (TTM)-56.94%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%325.91%
Revenue 1Y (TTM)-30.08%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%462.22%
3.2 Future
DBAN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.48% yearly.
Based on estimates for the next years, DBAN will show a decrease in Revenue. The Revenue will decrease by -0.23% on average per year.
EPS Next Y-39.86%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
EPS Next 5YN/A
Revenue Next Year-12.69%
Revenue Next 2Y-3.2%
Revenue Next 3Y-0.23%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.16, the valuation of DBAN can be described as reasonable.
78.30% of the companies in the same industry are more expensive than DBAN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.21. DBAN is valued rather cheaply when compared to this.
DBAN is valuated reasonably with a Price/Forward Earnings ratio of 9.07.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DBAN indicates a rather cheap valuation: DBAN is cheaper than 89.62% of the companies listed in the same industry.
DBAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.16 | ||
| Fwd PE | 9.07 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, DBAN is valued a bit cheaper than 67.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.17 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
DBAN's earnings are expected to decrease with -14.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
5. Dividend
5.1 Amount
DBAN has a Yearly Dividend Yield of 3.98%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 6.56, DBAN pays a bit more dividend than its industry peers.
DBAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.98% |
5.2 History
The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DBAN pays out 39.57% of its income as dividend. This is a sustainable payout ratio.
The Dividend Rate of DBAN has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP39.57%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
FRA:DBAN (5/9/2025, 7:00:00 PM)
27
+0.5 (+1.89%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners13.48%
Inst Owner ChangeN/A
Ins Owners10%
Ins Owner ChangeN/A
Market Cap507.60M
Analysts88.33
Price Target41.3 (52.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.98% |
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP39.57%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.53%
PT rev (3m)-4.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-11.96%
EPS NY rev (3m)-4.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.16 | ||
| Fwd PE | 9.07 | ||
| P/S | 4.67 | ||
| P/FCF | 41.17 | ||
| P/OCF | 38.91 | ||
| P/B | 0.74 | ||
| P/tB | 0.8 | ||
| EV/EBITDA | N/A |
EPS(TTM)2.42
EY8.96%
EPS(NY)2.98
Fwd EY11.03%
FCF(TTM)0.66
FCFY2.43%
OCF(TTM)0.69
OCFY2.57%
SpS5.78
BVpS36.61
TBVpS33.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.2% | ||
| ROE | 6.9% | ||
| ROCE | 5.68% | ||
| ROIC | 4% | ||
| ROICexc | 4.85% | ||
| ROICexgc | 5.23% | ||
| OM | 45.84% | ||
| PM (TTM) | 43.72% | ||
| GM | 95.08% | ||
| FCFM | 11.35% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-36.14%
ROICexcg growth 5Y-8.15%
ROICexc growth 3Y-37.69%
ROICexc growth 5Y-9.49%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 11.27 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.66% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 25.95% | ||
| Current Ratio | 4.62 | ||
| Quick Ratio | 4.62 | ||
| Altman-Z | 2.78 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.94%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%325.91%
EPS Next Y-39.86%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.08%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%462.22%
Revenue Next Year-12.69%
Revenue Next 2Y-3.2%
Revenue Next 3Y-0.23%
Revenue Next 5YN/A
EBIT growth 1Y-53.88%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-17.08%
EBIT Next 3Y0.97%
EBIT Next 5YN/A
FCF growth 1Y43.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.54%
OCF growth 3YN/A
OCF growth 5YN/A